Cargando…

Functional MRI techniques demonstrate early vascular changes in renal cell cancer patients treated with sunitinib: a pilot study

Objective: To assess the early vascular effects of sunitinib in patients with renal cell carcinoma (RCC) with diffusion-weighted magnetic resonance imaging (DWI), dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) and T2* perfusion MRI. Patients and methods: In 10 patients with abdomin...

Descripción completa

Detalles Bibliográficos
Autores principales:	Desar, I.M.E., ter Voert, E.G.W., Hambrock, Th., van Asten, J.J.A., van Spronsen, D.J., Mulders, P.F.A., Heerschap, A., van der Graaf, W.T.A., van Laarhoven, H.W.M., van Herpen, C.M.L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	e-Med 2011
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3266589/ https://www.ncbi.nlm.nih.gov/pubmed/22245974 http://dx.doi.org/10.1102/1470-7330.2011.0032

Ejemplares similares

The complexity of sunitinib dosing in renal cell cancer patients
por: Desar, Ingrid M.E., et al.
Publicado: (2012)

Impairment of cognitive functioning during Sunitinib or Sorafenib treatment in cancer patients: a cross sectional study
por: Mulder, Sasja F, et al.
Publicado: (2014)

Multimodality Imaging to Predict Response to Systemic Treatment in Patients with Advanced Colorectal Cancer
por: Heijmen, Linda, et al.
Publicado: (2015)

Controversies in upper gastrointestinal oncology: neoadjuvant chemoradiotherapy versus neoadjuvant chemotherapy in oesophageal adenocarcinoma
por: Petrillo, A., et al.
Publicado: (2022)

Sex differences in patients with gastrointestinal stromal tumours: do they exist and does it affect survival?
por: IJzerman, N.S., et al.
Publicado: (2022)

The relationship between sunitinib exposure and both efficacy and toxicity in real‐world patients with renal cell carcinoma and gastrointestinal stromal tumour
por: Westerdijk, Kim, et al.
Publicado: (2020)

Imatinib, sunitinib and pazopanib: From flat‐fixed dosing towards a pharmacokinetically guided personalized dose
por: Westerdijk, Kim, et al.
Publicado: (2020)

Magnetic Resonance Spectroscopic Imaging and Volumetric Measurements of the Brain in Patients with Postcancer Fatigue: A Randomized Controlled Trial
por: Prinsen, Hetty, et al.
Publicado: (2013)

Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study
por: Younger, E., et al.
Publicado: (2021)

A validated HPLC-MS/MS method for simultaneously analyzing curcumin, demethoxycurcumin, bisdemethoxycurcumin, tetra-hydrocurcumin and piperine in human plasma, urine or feces
por: Kroon, M.A.G.M., et al.
Publicado: (2023)

Convolutional neural networks to predict brain tumor grades and Alzheimer’s disease with MR spectroscopic imaging data
por: Acquarelli, Jacopo, et al.
Publicado: (2022)

A phase I dose-escalation study to evaluate safety and tolerability of sorafenib combined with sirolimus in patients with advanced solid cancer
por: Desar, I M E, et al.
Publicado: (2010)

Time to reimbursement of novel anticancer drugs in Europe: a case study of seven European countries
por: Post, H.C., et al.
Publicado: (2023)

Assessment of Blood Hemodynamics by USPIO-Induced R(1) Changes in MRI of Murine Colon Carcinoma
por: Gambarota, Giulio, et al.
Publicado: (2010)

Short- and long-term impact of cancer on employment and financial outcomes of adolescents and young adults (AYAs): a large population-based case-control registry study in the Netherlands
por: Janssen, S.H.M., et al.
Publicado: (2022)

Weight change during chemotherapy in breast cancer patients: a meta-analysis
por: van den Berg, M.M.G.A., et al.
Publicado: (2017)

Myelosuppression by sunitinib is flt-3 genotype dependent
por: van Erp, N P, et al.
Publicado: (2010)

Impact of the coronavirus disease 2019 pandemic on cancer treatment: the patients’ perspective
por: de Joode, K., et al.
Publicado: (2020)

Photoactivation of lysosomally sequestered sunitinib after angiostatic treatment causes vascular occlusion and enhances tumor growth inhibition
por: Nowak-Sliwinska, P, et al.
Publicado: (2015)

Reply: Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
por: van der Veldt, A A M, et al.
Publicado: (2009)

External Validation of the Dutch SOURCE Survival Prediction Model in Belgian Metastatic Oesophageal and Gastric Cancer Patients
por: van Kleef, J.J., et al.
Publicado: (2020)

Physiological and neurophysiological determinants of postcancer fatigue: design of a randomized controlled trial
por: Prinsen, Hetty, et al.
Publicado: (2012)

Predictive factors for severe toxicity of sunitinib in unselected patients with advanced renal cell cancer
por: van der Veldt, A A M, et al.
Publicado: (2008)

Quantitative and qualitative changes in platelet traits of sunitinib-treated patients with renal cell carcinoma in relation to circulating sunitinib levels: a proof-of-concept study
por: Tullemans, Bibian M. E., et al.
Publicado: (2022)

Decreased exposure to sunitinib due to concomitant administration of ifosfamide: results of a phase I and pharmacokinetic study on the combination of sunitinib and ifosfamide in patients with advanced solid malignancies
por: Hamberg, P, et al.
Publicado: (2010)

Elevated brain glutamate levels in type 1 diabetes: correlations with glycaemic control and age of disease onset but not with hypoglycaemia awareness status
por: Wiegers, Evita C., et al.
Publicado: (2019)

Promises and challenges of positron emission tomography for assessment of sarcoma in daily clinical practice
por: van de Luijtgaarden, A.C.M., et al.
Publicado: (2008)

Choi response criteria for early prediction of clinical outcome in patients with metastatic renal cell cancer treated with sunitinib
por: van der Veldt, A A M, et al.
Publicado: (2010)

Effect of lactate administration on cerebral blood flow during hypoglycemia in people with type 1 diabetes
por: van Meijel, Lian A, et al.
Publicado: (2022)

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2015)

The age-related impact of surviving sarcoma on health-related quality of life: data from the SURVSARC study
por: Drabbe, C., et al.
Publicado: (2021)

Exposure‐toxicity relationship of cabozantinib in patients with renal cell cancer and salivary gland cancer
por: Krens, Stefanie D., et al.
Publicado: (2021)

Editorial Comment: Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Trial
por: Bex, A, et al.
Publicado: (2020)

Simultaneous Recording of the Uptake and Conversion of Glucose and Choline in Tumors by Deuterium Metabolic Imaging
por: Veltien, Andor, et al.
Publicado: (2021)

Increased levels of choline metabolites are an early marker of docetaxel treatment response in BRCA1-mutated mouse mammary tumors: an assessment by ex vivo proton magnetic resonance spectroscopy
por: van Asten, Jack JA, et al.
Publicado: (2015)

(18)F-FLT-PET for Response Evaluation of MEK Inhibitor Selumetinib (AZD6244, ARRY-142886) in Patients with Solid Tumors
por: Desar, Ingrid M. E., et al.
Publicado: (2012)

The periodic system of chemical elements: a history of the first hundred years
por: Van Spronsen, Johannes W
Publicado: (1969)

A Phase Ib dose-escalation study to evaluate safety and tolerability of the addition of the aminopeptidase inhibitor tosedostat (CHR-2797) to paclitaxel in patients with advanced solid tumours
por: van Herpen, C M L, et al.
Publicado: (2010)

Platelet function is disturbed by the angiogenesis inhibitors sunitinib and sorafenib, but unaffected by bevacizumab
por: Walraven, Maudy, et al.
Publicado: (2018)

601TiP First-in-human phase I study of a novel oral Wee1 inhibitor (Debio 0123) in combination with carboplatin in patients with advanced solid tumours
por: Gelderblom, H., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_u3dc3ggde1r1qccipps8ntprun